Of the 453 women with endometrial cancer, the positive yield was 11.9% (n = 54); 7.3% (n = 33) of these were within a Lynch gene, most commonly MSH6. CHEK2 also had a significant number of positives (n = 7), with an overall frequency of 1.5%. This evidence concerns the gene CHEK2 and endometrial cancer.